188 related articles for article (PubMed ID: 35442716)
21. Third-line chemotherapy and novel agents for metastatic germ cell tumors.
Veenstra CM; Vaughn DJ
Hematol Oncol Clin North Am; 2011 Jun; 25(3):577-91, ix. PubMed ID: 21570610
[TBL] [Abstract][Full Text] [Related]
22. Biological markers of cisplatin resistance in advanced testicular germ cell tumours.
García-Velasco A; Durán I; García E; Tarón M; Ballestín C; Castellanos D; Cortés-Funés H; Paz-Ares L
Clin Transl Oncol; 2012 Jun; 14(6):452-7. PubMed ID: 22634534
[TBL] [Abstract][Full Text] [Related]
23. Identification of genomic changes associated with cisplatin resistance in testicular germ cell tumor cell lines.
Noel EE; Perry J; Chaplin T; Mao X; Cazier JB; Joel SP; Oliver RT; Young BD; Lu YJ
Genes Chromosomes Cancer; 2008 Jul; 47(7):604-13. PubMed ID: 18384131
[TBL] [Abstract][Full Text] [Related]
24. Clonal analyses of refractory testicular germ cell tumors.
Barrett MT; Lenkiewicz E; Malasi S; Stanton M; Slack J; Andrews P; Pagliaro L; Bryce AH
PLoS One; 2019; 14(3):e0213815. PubMed ID: 30870501
[TBL] [Abstract][Full Text] [Related]
25. Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents.
Schneider DT; Schuster AE; Fritsch MK; Calaminus G; Göbel U; Harms D; Lauer S; Olson T; Perlman EJ
Genes Chromosomes Cancer; 2002 May; 34(1):115-25. PubMed ID: 11921289
[TBL] [Abstract][Full Text] [Related]
26. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
Wermann H; Stoop H; Gillis AJ; Honecker F; van Gurp RJ; Ammerpohl O; Richter J; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Pathol; 2010 Aug; 221(4):433-42. PubMed ID: 20593487
[TBL] [Abstract][Full Text] [Related]
27. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
[TBL] [Abstract][Full Text] [Related]
28. A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.
Necchi A; Pond GR; Nicolai N; Giannatempo P; Raggi D; Adra N; Hanna NH; Salvioni R; Einhorn LH; Albany C
Clin Genitourin Cancer; 2017 Apr; 15(2):306-312.e3. PubMed ID: 27594554
[TBL] [Abstract][Full Text] [Related]
29. Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study.
Oechsle K; Honecker F; Cheng T; Mayer F; Czaykowski P; Winquist E; Wood L; Fenner M; Glaesener S; Hartmann JT; Chi K; Bokemeyer C; Kollmannsberger C
Ann Oncol; 2011 Dec; 22(12):2654-2660. PubMed ID: 21415240
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial.
Mego M; Svetlovska D; Angelis V D; Kalavska K; Lesko P; Makovník M; Obertova J; Orszaghova Z; Palacka P; Rečková M; Rejlekova K; Z SM; Mardiak J; Chovanec M
Invest New Drugs; 2022 Oct; 40(5):1080-1086. PubMed ID: 35763178
[TBL] [Abstract][Full Text] [Related]
31. [Studies on nuclear DNA content in testicular germ cell tumors using flow cytometry].
Kashiwagi A
Hokkaido Igaku Zasshi; 1992 Nov; 67(6):801-14. PubMed ID: 1336479
[TBL] [Abstract][Full Text] [Related]
32. Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors.
Rao PH; Houldsworth J; Palanisamy N; Murty VV; Reuter VE; Motzer RJ; Bosl GJ; Chaganti RS
Cancer Res; 1998 Oct; 58(19):4260-3. PubMed ID: 9766648
[TBL] [Abstract][Full Text] [Related]
33. Epigenetics: a way to understand the origin and biology of testicular germ cell tumors.
Okamoto K
Int J Urol; 2012 Jun; 19(6):504-11. PubMed ID: 22375557
[TBL] [Abstract][Full Text] [Related]
34. New insights into germ cell tumor genomics.
Lafin JT; Bagrodia A; Woldu S; Amatruda JF
Andrology; 2019 Jul; 7(4):507-515. PubMed ID: 30896089
[TBL] [Abstract][Full Text] [Related]
35. Pathobiology of testicular germ cell tumors: views and news.
Looijenga LH; Oosterhuis JW
Anal Quant Cytol Histol; 2002 Oct; 24(5):263-79. PubMed ID: 12408559
[TBL] [Abstract][Full Text] [Related]
36. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
[TBL] [Abstract][Full Text] [Related]
37. Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition.
Cavallo F; Graziani G; Antinozzi C; Feldman DR; Houldsworth J; Bosl GJ; Chaganti RS; Moynahan ME; Jasin M; Barchi M
PLoS One; 2012; 7(12):e51563. PubMed ID: 23251575
[TBL] [Abstract][Full Text] [Related]
38. The component of the m
Miranda-Gonçalves V; Lobo J; Guimarães-Teixeira C; Barros-Silva D; Guimarães R; Cantante M; Braga I; Maurício J; Oing C; Honecker F; Nettersheim D; Looijenga LHJ; Henrique R; Jerónimo C
J Exp Clin Cancer Res; 2021 Aug; 40(1):268. PubMed ID: 34446080
[TBL] [Abstract][Full Text] [Related]
39. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors.
Korkola JE; Houldsworth J; Feldman DR; Olshen AB; Qin LX; Patil S; Reuter VE; Bosl GJ; Chaganti RS
J Clin Oncol; 2009 Nov; 27(31):5240-7. PubMed ID: 19770384
[TBL] [Abstract][Full Text] [Related]
40. Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications.
Kalavska K; Conteduca V; De Giorgi U; Mego M
Curr Cancer Drug Targets; 2018; 18(10):967-978. PubMed ID: 29295694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
